Pharmaceutical company Merck in Whitehouse Station announced on May 6 it has sold its consumer care line, including the Dr. Scholl’s and Claritin brands, to Bayer AG, a health-care company in Leverkusen, Germany, for $14 billion. Merck is advised by a team from Morgan, Lewis & Bockius in Princeton, led by attorneys David Glazer, Alan Leeds and Randall Sunberg, and groups from Fried, Frank, Harris, Shriver & Jacobson in New York City and Cleary Gottlieb Steen & Hamilton in Brussels. Bayer is advised by Matthew Hurd of New York City’s Sullivan & Cromwell, as well as by teams from Jones Day in Washington, D.C., Allen & Overy in Frankfurt, and Stuttgart-based firm Gleiss Lutz.
$58M Buy for Medicines Co.
Tenaxis Medical Inc., a surgical sealant manufacturer in Mountain View, Calif., announced on April 23 its sale to The Medicines Co. a pharmaceutical company in Parsippany, for $58 million plus up to $112 million in profit-related payments.
Sanofi Unit Sells for $6.5M
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
